MITOCHONDRIAL, TAU, AND AGING
MITOCHONDRIAL, TAU, AND AGING
批准号:
7183914
负责人:
Simon Melov
金额:
$28.7万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2011-11-30
关键词:
AdultAgeAgingAlzheimer&aposs DiseaseAnemiaAnimal ModelAnimalsAntioxidantsAttentionAttenuatedBedsBioenergeticsBrainBrain-Derived Neurotrophic FactorBreedingCardiomyopathiesCell DeathCharacteristicsCollaborationsConceptionsContractsCorpus striatum structureDataDevelopmentDiseaseEmployee StrikesEncephalopathiesEnzymesEventFinancial compensationFoundationsFunctional disorderGene ExpressionGene Expression ProfilingGene SilencingGenomic InstabilityGliosisGlutamatesHippocampus (Brain)HousingHydrogen PeroxideHyperlipidemiaInterventionKnock-outKnockout MiceLifeLinkLiverLongevityMass Spectrum AnalysisMethodologyMitochondriaModelingMolecular ProfilingMusMutationNeonatalNerve DegenerationNeurodegenerative DisordersNeuronsOutcomeOxidative StressPathologyPersonal SatisfactionPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPrincipal InvestigatorPrion DiseasesProductionProteomicsPublicationsPublishingRNA InterferenceReactive Oxygen SpeciesReportingResearch PersonnelRespirationSOD2 geneScreening procedureSiteStagingStatistically SignificantStressSuperoxidesSynapsesSynaptosomesTechniquesTechnologyTestingTimeTissuesTransgenic AnimalsTransgenic MiceWeekWestern Blottingage effectage relatedagedaging braindayembryonic stem cellfeedinggene functionhuman SOD2 proteininsightinterestmitochondrial dysfunctionmouse modelneuropathologynovelpreventprogramsresponsetau Proteinstau dysfunctiontau phosphorylation
中文摘要
缺乏线粒体超氧化物歧化酶(SOD2)的小鼠显示线粒体受损!函数
英文摘要
Mice lacking mitochondrial superoxide dismutase (SOD2) show compromised mitochondria! function in
association with neonatal lethality and cardiomyopathy, anemia, hyperlipidemia in the liver, enhanced cell
death and genomic instability, and excess production of reactive oxygen species. Perhaps the most striking
phenotypes that develop in these mice are centered in the brain. Sod2 null mice over two weeks of age
rapidly develop a regionally specific spongiform encephalopathy, accompanied by gliosis in addition to a
neurodegeneration not colocalized with the encephalopathy itself. We have characterized many of the
phenotypes in sod2 null mice in conjunction with effective antioxidant interventions that prevent or
attenuate the pathological consequences of mitochondrial oxidative stress.
This proposal will test the hypothesis that increasing mitochondrial oxidative stress over time is associated
with synaptic dysfunction and hyperphosphorylation of tau. We propose that interventions that reduce
mitochondrial oxidative stress will also reduce synaptic dysfunction and tau pathology. We also propose
that mitochondrial oxidative stress significantly impacts brain function in adult mice, and will test this via
characterization of an temporal and tissue specific inducible knockout of sod2. We propose to test these
hypotheses via the following specific aims:
1. Characterization of synaptosomal function with increasing age in sod2 nullizygous mice. This
specific aim will test the hypothesis that between 10and 20 days of age, synaptosomes from sod2
nullizygous mice have increased ROSthat directly impacts mitochondrial function.
2. Characterize the development of hyperphosphorylation of tau in sod2 nullizygous mice though
quantitative Western blotting and gene expression profiling. We have made the novel
observation that tau is hyperphosphorylated as a result of mitochondrial oxidative stress. This
specific aim will characterize the development of hyperphosphorylation in tau in sod2 null mice
through proteomic studies on tau, in conjunction with gene expression profiling.
3. Characterization of a neuronal specific inducible knockout of sod2. Having characterized the
consequences of mitochondrial oxidative stress in synaptosomes and tau, we will study the
consequences of mitochondrial dysfunction in adult mouse brain. Specifically we will a) evaluate
neuropathology of inducible sod2 null mice at various times throughout their lives to evaluate the
effect of age on pathological outcomes from mitochondrial oxidative stress triggered at different
times throughout life, and b) evaluate the phosphorylation status of tau, using age as an
independent variable.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mapping and validating senescent cells in human muscle, ovary and breast
-
批准号:10684955
-
项目类别:
-
资助金额:$89.08万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Single cell analysis core
-
批准号:10647776
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Single cell analysis core
-
批准号:10491078
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Evaluating diverse technologies for detecting and validating senescent cells in vivo
-
批准号:10376470
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Single cell analysis core
-
批准号:10187411
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Senescent cell mapping, identification and validation for human somatic and reproductive tissues
-
批准号:10684946
-
项目类别:
-
资助金额:$223.71万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Mapping and validating senescent cells in human muscle, ovary and breast
-
批准号:10376499
-
项目类别:
-
资助金额:$99.2万
-
财政年份:2021
-
负责人:Simon Melov
-
依托单位:
Geroscience Technology Core
-
批准号:10649635
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2020
-
负责人:Simon Melov
-
依托单位:
Geroscience Technology Core
-
批准号:10424594
-
项目类别:
-
资助金额:$6.29万
-
财政年份:2020
-
负责人:Simon Melov
-
依托单位:
Geroscience Technology Core
-
批准号:10261432
-
项目类别:
-
资助金额:$4.61万
-
财政年份:2020
-
负责人:Simon Melov
-
依托单位:
Geroscience Technology Core
-
批准号:10044925
-
项目类别:
-
资助金额:$4.61万
-
财政年份:2020
-
负责人:Simon Melov
-
依托单位:
Role of cellular senescence in cardiovascular aging
-
批准号:10160622
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2018
-
负责人:Simon Melov
-
依托单位:
Role of cellular senescence in cardiovascular aging
-
批准号:10393209
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2018
-
负责人:Simon Melov
-
依托单位:
Analysis of gene expression and cell function in single cell cortical osteoblasts
-
批准号:8583136
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2013
-
负责人:Simon Melov
-
依托单位:
Analysis of gene expression and cell function in single cell cortical osteoblasts
-
批准号:8697013
-
项目类别:
-
资助金额:$19.82万
-
财政年份:2013
-
负责人:Simon Melov
-
依托单位:
Core--GENOMICS
-
批准号:6948002
-
项目类别:
-
资助金额:$6.04万
-
财政年份:2005
-
负责人:Simon Melov
-
依托单位:
Comparative Functional Genomics of Longevity Assurance
-
批准号:7094160
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2004
-
负责人:Simon Melov
-
依托单位:
Comparative Functional Genomics of Longevity Assurance
-
批准号:6949978
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2004
-
负责人:Simon Melov
-
依托单位:
Comparative Functional Genomics of Longevity Assurance
-
批准号:6818312
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2004
-
负责人:Simon Melov
-
依托单位:
OXIDATIVE STRESS AND DISEASE
-
批准号:6287243
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2001
-
负责人:Simon Melov
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: